Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels

Published:2011-02 Issue:2 Volume:214 Page:295-300
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Bot Ilze,Jukema J. Wouter,Lankhuizen Inge M.,van Berkel Theo J.C.,Biessen Erik A.L.

Funder

Netherlands Organization for Scientific Research (I.B.)

Netherlands Heart Foundation (E.B.)

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Atherosclerosis, an inflammatory disease;Ross;N Engl J Med,1999

2. Mechanisms of plaque vulnerability and rupture;Shah;J Am Coll Cardiol,2003

3. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group;Shepherd;N Engl J Med,1995

4. Modulation of inflammatory mediators and PPARgamma and NFkappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro;Zelvyte;Pharmacol Res,2002

5. Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I;Martin;J Clin Invest,2001

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atorvastatin rescues hyperhomocysteinemia-induced cognitive deficits and neuroinflammatory gene changes;Journal of Neuroinflammation;2023-09-01

2. Effect of pharmacologic anti-atherosclerotic therapy on carotid intraplaque neovascularization: A systematic review;Journal of Clinical Lipidology;2023-05

3. Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3/CPT1 pathway;Biomedicine & Pharmacotherapy;2023-01

4. Mouse models of atherosclerosis in translational research;Trends in Pharmacological Sciences;2022-11

5. Integrated pyroptosis measurement and metabolomics to elucidate the effect and mechanism of tangzhiqing on atherosclerosis;Frontiers in Physiology;2022-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3